Search

Search Constraints

You searched for: Author/Creator Dinner, Shira

Search Results

1. A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors. (7th November 2013)

2. Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. Issue 7 (1st December 2020)

4. Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival. Issue 7 (30th March 2022)

5. A phase 1, open‐label, dose‐escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma. (4th April 2016)

10. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis. (23rd February 2013)